Explore the newest and archived press releases about AOP Orphan, its products, studies and cooperations. We will be happy to answer any questions or comments you may have via firstname.lastname@example.org
7. 12. 2020
27. 10. 2020
12. 10. 2020
22. 9. 2020
21. 8. 2020
17. 3. 2020
Rare disease pioneer AOP Orphan takes over two health care companies strengthening its position in Europe as well as Austria as a research- and business hub.
"From the beginning, it was our priority to preserve all existing jobs and we have done just that. By developing innovative therapies and a broader territorial presence, we are convinced that we will continue to generate significant growth!"
Narcolepsy Awareness Day, Sep 22, 2020
Narcolepsy is a rare lifelong neurological disorder that affects the natural cycles of sleeping and waking. It is characterized by excessive sleepiness during the day. This rare disease affects 2–5 out of every 10,000 people. No cure of the disease is currently possible. Therefore the treatment concentrates on relieving the symptoms as far as possible.
Huntington’s Disease Awareness May, 2020
"If you get diagnosed do not hide your head in the sand. Stay open, positive and keep up the hope for a cure. It is important to go on with regular life as long as possible, for example to continue working, meeting friends and family, having hobbies! Such non-medical treatments as regular exercising, physiotherapy, logotherapy and massage etc also have a positive impact!"
PH Awareness Day May 5, 2020
"The time taken to establish the correct diagnosis of chronic thromboembolic pulmonary hypertension is on average about 14 months. However, the disease process starts much earlier - at a time when nobody has any idea about pulmonary hypertension. I know of one case that took 30 years to turn into a manifested disease!"
MPN Awareness Day on Sep 12, 2019
"MPNs is a chronic haematological disease group caused by a stem-cell disorder."
We believe that open communication is essential – not just in our day-to-day contact with business associates, but also with prospective partners, media, interested parties who are not yet familiar with AOP Orphan. We will be pleased to answer any questions you may have about the company, its products, studies, pipeline and overall plans.